Michael Nohaile's most recent trade in Fulgent Genetics Inc was a trade of 6,311 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fulgent Genetics Inc | Michael Nohaile | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 6,311 | 6,311 | - | - | Stock Option (Right to Buy) | |
| Fulgent Genetics Inc | Michael Nohaile | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 4,491 | 19,020 (0%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Michael Nohaile | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 8,000 | 14,529 (0%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Michael Nohaile | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 3,380 | 3,380 | - | - | Stock Option (Right to Buy) | |
| Fulgent Genetics Inc | Michael Nohaile | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 2,529 | 6,529 (0%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Michael Nohaile | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Fulgent Genetics Inc | Michael Nohaile | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 4,000 | 4,000 (0%) | 0% | 0 | Common Stock |